{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:45:35Z","timestamp":1791279935238,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T00:00:00Z","timestamp":1066780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1038\/sj.ejhg.5201102","type":"journal-article","created":{"date-parts":[[2003,10,15]],"date-time":"2003-10-15T09:06:35Z","timestamp":1066208795000},"page":"59-65","source":"Crossref","is-referenced-by-count":222,"title":["Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy"],"prefix":"10.1038","volume":"12","author":[{"given":"Catia","family":"Andreassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Angelozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco D","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Boninsegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Villanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,22]]},"reference":[{"key":"BF5201102_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BF5201102_CR2","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307\u20136311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF5201102_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW et al: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN. Hum Mol Genet 1999; 8: 1177\u20131183.","journal-title":"Hum Mol Genet"},{"key":"BF5201102_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/515465","volume":"69","author":"PE McAndrew","year":"1997","unstructured":"McAndrew PE, Parsons DW, Simard LR et al: Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNt and SMNc gene copy number. Am J Hum Genet 1997; 69: 1411\u20131422.","journal-title":"Am J Hum Genet"},{"key":"BF5201102_CR5","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/hmg\/8.13.2525","volume":"8","author":"T Vitali","year":"1999","unstructured":"Vitali T, Sossi V, Tiziano F et al: Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role of SMN2 in the modulation of disease severity in SMA patients. Hum Mol Genet 1999; 8: 2525\u20132532.","journal-title":"Hum Mol Genet"},{"key":"BF5201102_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0960-8966(99)00137-6","volume":"10","author":"C Brahe","year":"2000","unstructured":"Brahe C : Copies of the survival motor neuron gene in spinal muscular atrophy: the more, the better. Neuromusc Disord 2000; 10: 274\u2013275.","journal-title":"Neuromusc Disord"},{"key":"BF5201102_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TI, Wirth B : Quantitative analysis of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358\u2013368.","journal-title":"Am J Hum Genet"},{"key":"BF5201102_CR8","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu Q, Dreyfuss G : A novel nuclear structure containing the survival of motor neurons protein. EMBO J 1996; 15: 3555\u20133565.","journal-title":"EMBO J"},{"key":"BF5201102_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265\u2013269.","journal-title":"Nat Genet"},{"key":"BF5201102_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE et al: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205\u20131214.","journal-title":"Hum Mol Genet"},{"key":"BF5201102_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.ejhg.5200286","volume":"7","author":"AL Patrizi","year":"1999","unstructured":"Patrizi AL, Tiziano F, Zappata S, Donati A, Neri G, Brahe C : SMN protein analysis in fibroblast, amniocyte, and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999; 7: 301\u2013309.","journal-title":"Eur J Hum Genet"},{"key":"BF5201102_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","volume":"191","author":"RG Miller","year":"2001","unstructured":"Miller RG, Moore DH, Dronsky V et al: A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci 2001; 191: 127\u2013131.","journal-title":"J Neurol Sci"},{"key":"BF5201102_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00002060-200009000-00005","volume":"79","author":"AC Tzeng","year":"2000","unstructured":"Tzeng AC, Cheng J, Fryczynski H et al: A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report. Am J Phys Med Rehabil 2000; 79: 435\u2013440.","journal-title":"Am J Phys Med Rehabil"},{"key":"BF5201102_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/WNL.59.4.609","volume":"59","author":"M Kinali","year":"2002","unstructured":"Kinali M, Mercuri E, Main M et al: Pilot trial of albuterol in spinal muscular atrophy. Neurology 2002; 59: 609\u2013610.","journal-title":"Neurology"},{"key":"BF5201102_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/BF03401830","volume":"6","author":"S Baron-Delage","year":"2000","unstructured":"Baron-Delage S, Abadie A, Echaniz-Laguna A, Melki J, Beretta L : Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes. Mol Med 2000; 6: 957\u2013968.","journal-title":"Mol Med"},{"key":"BF5201102_CR16","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J et al: Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 2001; 10: 2841\u20132849.","journal-title":"Hum Mol Genet"},{"key":"BF5201102_CR17","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"J-G Chang","year":"2001","unstructured":"Chang J-G, Hsieh-Li H-M, Jong Y-J, Wang NM, Tsai C-H, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF5201102_CR18","unstructured":"Vitali T, Tiziano F, Neri G, Brahe C : SMN2 gene activation by sodium butyrate and acetyl-L-carnitine in cell cultures from SMA patients; Abstract, Fifth Annual North American\/International Spinal Muscular Atrophy Research and Clinical Meeting; June 22\u201324, 2001; Chicago."},{"issue":"Suppl","key":"BF5201102_CR19","first-page":"A2445","volume":"71","author":"FD Tiziano","year":"2002","unstructured":"Tiziano FD, Andreassi C, Angelozzi C et al: Upregulation of SMN2 gene expression by 4-phenylbutyrate: relevance for a therapeutic approach to spinal muscular atrophy. Am J Hum Genet 2002; 71 (Suppl): A2445.","journal-title":"Am J Hum Genet"},{"key":"BF5201102_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1056\/NEJM199609193351204","volume":"335","author":"NE Maestri","year":"1996","unstructured":"Maestri NE, Brusilow SW, Clissold DB, Bassett S : Long term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 1996; 335: 855\u2013859.","journal-title":"N Engl J Med"},{"key":"BF5201102_CR21","first-page":"2292","volume":"7","author":"J Gilbert","year":"2001","unstructured":"Gilbert J, Baker SD, Bowling MK et al: A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies. Clin Cancer Res 2001; 7: 2292\u20132300.","journal-title":"Clin Cancer Res"},{"key":"BF5201102_CR22","first-page":"4334","volume":"6","author":"T Davis","year":"2000","unstructured":"Davis T, Kennedy C, Chiew Y-E, Clarke CL, deFazio A : Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Clin Cancer Res 2000; 6: 4334\u20134342.","journal-title":"Clin Cancer Res"},{"key":"BF5201102_CR23","first-page":"941","volume":"294","author":"SA McGrath-Morrow","year":"2000","unstructured":"McGrath-Morrow SA, Stahl JL : G1 phase growth arrest and induction of p21waf1\/Cip\/Sdi1 in IB3-1 cells treated with 4-sodium phenylbutyrate. J Pharmacol Exp Therap 2000; 294: 941\u2013947.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF5201102_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","volume":"84","author":"GJ Dover","year":"1994","unstructured":"Dover GJ, Brusilow S, Charache S : Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium pehylbutyrate. Blood 1994; 84: 339\u2013343.","journal-title":"Blood"},{"key":"BF5201102_CR25","first-page":"1755","volume":"3","author":"SD Gore","year":"1997","unstructured":"Gore SD, Samid D, Weng L-J : Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells. Clin Cancer Res 1997; 3: 1755\u20131762.","journal-title":"Clin Cancer Res"},{"key":"BF5201102_CR26","first-page":"379","volume":"2","author":"MA Carducci","year":"1996","unstructured":"Carducci MA, Nelson JB, Chantack KM et al: Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res 1996; 2: 379\u2013387.","journal-title":"Clin Cancer Res"},{"key":"BF5201102_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-3101(24)00072-0","volume":"23","author":"SW Brusilow","year":"1996","unstructured":"Brusilow SW, Maestri NE : Urea cycle disorders: diagnosis, pathophysiology and therapy. Adv Pediat 1996; 23: 127\u2013170.","journal-title":"Adv Pediat"},{"key":"BF5201102_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/3242","volume":"4","author":"S Kemp","year":"1998","unstructured":"Kemp S, Wei H-M, Lu J-F et al: Gene redundancy of pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med 1998; 4: 1261\u20131268.","journal-title":"Nat Med"},{"key":"BF5201102_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s002800000256","volume":"47","author":"S Berg","year":"2001","unstructured":"Berg S, Serabe B, Aleksic A et al: Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate. Cancer Chemother Pharmacol 2001; 47: 385\u2013390.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5201102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:39:09Z","timestamp":1704933549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5201102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF5201102"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5201102","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,22]]}}}